The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 05, 2012

Filed:

Oct. 16, 2007
Applicants:

David Chen, Singapore, SG;

Christopher L. Franklin, Keasbey, NJ (US);

Peter R. Guzzo, Niskayuna, NY (US);

Linus S. Lin, Westfield, NJ (US);

Michael M. C. Lo, Edison, NJ (US);

Ravi P. Nargund, East Brunswick, NJ (US);

Iyassu K. Sebhat, Jersey City, NJ (US);

Inventors:

David Chen, Singapore, SG;

Christopher L. Franklin, Keasbey, NJ (US);

Peter R. Guzzo, Niskayuna, NY (US);

Linus S. Lin, Westfield, NJ (US);

Michael M. C. Lo, Edison, NJ (US);

Ravi P. Nargund, East Brunswick, NJ (US);

Iyassu K. Sebhat, Jersey City, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4178 (2006.01); A61K 31/4164 (2006.01); C07D 471/04 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 233/64 (2006.01);
U.S. Cl.
CPC ...
Abstract

Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.


Find Patent Forward Citations

Loading…